AAAAAA
Results:
1-24
|
Results: 24
Authors:
Brunnenberg, M
Kovar, KA
Citation: M. Brunnenberg et Ka. Kovar, Stereospecific analysis of ecstasy-like N-ethyl-3,4-ethylenedioxyamphetamine and its metabolites in humans, J CHROMAT B, 751(1), 2001, pp. 9-18
Authors:
Essig, S
Kovar, KA
Citation: S. Essig et Ka. Kovar, Quantitative determination of phospholipids in a pharmaceutical drug by scanning and video densitometry, J AOAC INT, 84(4), 2001, pp. 1283-1286
Authors:
Stahlmann, S
Herkert, T
Roseler, C
Rager, I
Kovar, KA
Citation: S. Stahlmann et al., New sorbent for HPTLC-FTIR in situ determination of impurities in flurazepam, EUR J PH SC, 12(4), 2001, pp. 461-469
Authors:
Mayerhofer, A
Kovar, KA
Schmidt, WJ
Citation: A. Mayerhofer et al., Changes in serotonin, dopamine and noradrenaline levels in striatum and nucleus accumbens after repeated administration of the abused drug MDMA in rats, NEUROSCI L, 308(2), 2001, pp. 99-102
Authors:
Spitzer, M
Franke, B
Walter, H
Buechler, J
Wunderlich, AP
Schwab, M
Kovar, KA
Hermle, L
Gron, G
Citation: M. Spitzer et al., Enantio-selective cognitive and brain activation effects of N-ethyl-3,4-methylenedioxyamphetamine in humans, NEUROPHARM, 41(2), 2001, pp. 263-271
Authors:
Essig, S
Kovar, KA
Citation: S. Essig et Ka. Kovar, Fluorimetric determination of cinchocaine in a pharmaceutical drug by scanning and video densitometry, CHROMATOGR, 53(5-6), 2001, pp. 321-322
Authors:
Harms, A
Gundisch, D
Muller, CE
Kovar, KA
Citation: A. Harms et al., Development of a 5-hydroxytryptamine(2A) receptor binding assay for high throughput screening using 96-well microfilter plates, J BIOMOL SC, 5(4), 2000, pp. 269-277
Authors:
Buchler, J
Maichle-Mossmer, C
Kovar, KA
Citation: J. Buchler et al., Enantioselective production and crystal structure of the ecstasy analogue N-ethyl-3,4-methylenedioxyamphetamine-HCl (MDE) and its major metabolites MDA and HME, Z NATURFO B, 55(12), 2000, pp. 1124-1130
Authors:
Seyfried, J
Soldner, F
Kunz, WS
Schulz, JB
Klockgether, T
Kovar, KA
Wullner, U
Citation: J. Seyfried et al., Effect of 1-methyl-4-phenylpyridinium on glutathione in rat pheochromocytoma PC 12 cells, NEUROCHEM I, 36(6), 2000, pp. 489-497
Authors:
Seyfried, J
Evert, BO
Rundfeldt, C
Schulz, JB
Kovar, KA
Klockgether, T
Wullner, U
Citation: J. Seyfried et al., Flupirtine and retigabine prevent L-glutamate toxicity in rat pheochromocytoma PC 12 cells, EUR J PHARM, 400(2-3), 2000, pp. 155-166
Authors:
Kreth, KP
Kovar, KA
Schwab, M
Zanger, UM
Citation: Kp. Kreth et al., Identification of the human cytochromes P450 involved in the oxidative metabolism of "Ecstasy"-related designer drugs, BIOCH PHARM, 59(12), 2000, pp. 1563-1571
Authors:
Gouzoulis-Mayfrank, E
Thelen, B
Habermeyer, E
Kunert, HJ
Kovar, KA
Lindenblatt, H
Hermle, L
Spitzer, M
Sass, H
Citation: E. Gouzoulis-mayfrank et al., Psychopathological, neuroendocrine and autonomic effects of 3,4-methylenedioxyethylamphetamine (MDE), psilocybin and d-methamphetamine in healthy volunteers - Results of an experimental double blind placebo controlled study, PSYCHOPHAR, 142(1), 1999, pp. 41-50
Authors:
Kramer, E
Kovar, KA
Citation: E. Kramer et Ka. Kovar, On-line coupling of automated solid-phase extraction with high-performanceliquid chromatography and electrochemical detection - Quantitation of oxidizable drugs of abuse and their metabolites in plasma and urine, J CHROMAT B, 731(2), 1999, pp. 167-177
Authors:
Essig, S
Kovar, KA
Citation: S. Essig et Ka. Kovar, Impurity test of theophylline: Comparison of classical slit scanner with videodensitometry, J PL CHROM, 12(1), 1999, pp. 63-65
Authors:
Schulze-Alexandru, M
Kovar, KA
Vedani, A
Citation: M. Schulze-alexandru et al., Quasi-atomistic receptor surrogates for the 5-HT2A receptor: A 3D-QSAR study on hallucinogenic substances, QSAR, 18(6), 1999, pp. 548-560
Authors:
Muszynski, IC
Scapozza, L
Kovar, KA
Folkers, G
Citation: Ic. Muszynski et al., Quantitative structure-activity relationships of phenyltropanes as inhibitors of three monoamine transporters: Classical and CoMFA studies, QSAR, 18(4), 1999, pp. 342-353
Authors:
Gouzoulis-Mayfrank, E
Schreckenberger, M
Sabri, O
Arning, C
Thelen, B
Spitzer, M
Kovar, KA
Hermle, L
Bull, U
Sass, H
Citation: E. Gouzoulis-mayfrank et al., Neurometabolic effects of psilocybin, 3,4-methylenedioxyethylamphetamine (MDE) and d-methamphetamine in healthy volunteers - A double-blind, placebo-controlled PET study with [F-18]FDG, NEUROPSYCH, 20(6), 1999, pp. 565-581
Authors:
Gouzoulis-Mayfrank, E
Hermle, L
Kovar, KA
Sass, H
Citation: E. Gouzoulis-mayfrank et al., R. Thomasius, M. Schmolke, D. Kaus: Usage of MDMA (Ecstasy) - Psychiatric and medical consequences. Fortschr. Neurol. Psychiat. 65 (1997) 49-61, F NEUR PSYC, 67(12), 1999, pp. 574-575
Authors:
Sondermann, N
Kovar, KA
Citation: N. Sondermann et Ka. Kovar, Screening experiments of ecstasy street samples using near infrared spectroscopy, FOREN SCI I, 106(3), 1999, pp. 147-156
Authors:
Sondermann, N
Kovar, KA
Citation: N. Sondermann et Ka. Kovar, Identification of ecstasy in complex matrices using near-infrared spectroscopy, FOREN SCI I, 102(2-3), 1999, pp. 133-147
Authors:
Seyfried, J
Soldner, F
Schulz, JB
Klockgether, T
Kovar, KA
Wullner, U
Citation: J. Seyfried et al., Differential effects of L-buthionine sulfoximine and ethacrynic acid on glutathione levels and mitochondrial function in PC12 cells, NEUROSCI L, 264(1-3), 1999, pp. 1-4
Authors:
Patt, M
Gundisch, D
Wullner, U
Blocher, A
Kovar, KA
Machulla, HJ
Citation: M. Patt et al., N-[C-11]methyl-3,4-methylenedioxyamphetamine (Ecstasy) and 2-methyl-N-[C-11]methyl-4,5-methylenedioxyamphetamine: Synthesis and biodistribution studies, J RAD NUCL, 240(2), 1999, pp. 535-540
Authors:
Brunnenberg, M
Lindenblatt, H
Gouzoulis-Mayfrank, E
Kovar, KA
Citation: M. Brunnenberg et al., Quantitation of N-ethyl-3,4-methylenedioxyamphetamine and its major metabolites in human plasma by high-performance liquid chromatography and fluorescence detection, J CHROMAT B, 719(1-2), 1998, pp. 79-85
Authors:
Gouzoulis-Mayfrank, E
Heekeren, K
Thelen, B
Lindenblatt, H
Kovar, KA
Sass, H
Geyer, MA
Citation: E. Gouzoulis-mayfrank et al., Effects of the hallucinogen psilocybin on habituation and prepulse inhibition of the startle reflex in humans, BEHAV PHARM, 9(7), 1998, pp. 561-566
Risultati:
1-24
|